Life sciences industries including biotechnology, pharmaceuticals, chemicals and medical devices are not only faced with the risks of globalization, supply chain liability and litigious operating environments, but they are also exposed to cash flow issues as a result of falling volumes, while trying to mitigate against emerging risks like healthcare reform and intellectual property theft.
Willis has established a life sciences practice to respond to these new risks and the changing business model of the industry.
Continue Reading for Free
Register and gain access to:
- Breaking insurance news and analysis, on-site and via our newsletters and custom alerts
- Weekly Insurance Speak podcast featuring exclusive interviews with industry leaders
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the employee benefits and financial advisory markets on our other ALM sites, BenefitsPRO and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
